Your browser doesn't support javascript.
loading
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series.
Picard, Matthieu; Drolet, Jean-Philippe; Masse, Marie-Soleil; Filion, Charles A; ALMuhizi, Faisal; Fein, Michael; Copaescu, Ana; Isabwe, Ghislaine Annie C; Blaquière, Martin; Primeau, Marie-Noël.
Afiliação
  • Picard M; Division of Clinical Immunology and Allergy, Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montreal, Montreal, Quebec, Canada. Electronic address: matthieu.picard@umontreal.ca.
  • Drolet JP; Division of Clinical Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Quebec, Canada.
  • Masse MS; Division of Clinical Immunology and Allergy, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Filion CA; Division of Clinical Immunology and Allergy, Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montreal, Montreal, Quebec, Canada.
  • ALMuhizi F; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; Department of Internal Medicine, Security Forces Hospital Program, Riyadh, Saudi Arabia.
  • Fein M; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Copaescu A; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Department of Infectious Diseases, Cen
  • Isabwe GAC; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Blaquière M; Division of Allergy and Clinical Immunology, Department of Pediatrics, Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada.
  • Primeau MN; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Intégré de Santé et Services Sociaux (CISSS) de Laval, Laval, Quebec, Canada.
J Allergy Clin Immunol Pract ; 10(2): 620-625.e1, 2022 02.
Article em En | MEDLINE | ID: mdl-34949564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Drogas / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Drogas / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article